• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥漫性大 B 细胞淋巴瘤免疫球蛋白基因重排的分子特征:抗原驱动起源和 IGHV4-34 作为非生发中心 B 细胞亚型的一个特定亚群。

Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.

机构信息

Department of Hematology, University Hospital of Salamanca, Spain.

出版信息

Am J Pathol. 2012 Nov;181(5):1879-88. doi: 10.1016/j.ajpath.2012.07.028. Epub 2012 Sep 11.

DOI:10.1016/j.ajpath.2012.07.028
PMID:22982190
Abstract

The pathogenesis of diffuse large B-cell lymphoma (DLBCL) remains partially unknown. The analysis of the B-cell receptor of the malignant cells could contribute to a better understanding of the DLBCL biology. We studied the molecular features of the immunoglobulin heavy chain (IGH) rearrangements in 165 patients diagnosed with DLBCL not otherwise specified. Clonal IGH rearrangements were amplified according to the BIOMED-2 protocol and PCR products were sequenced directly. We also analyzed the criteria for stereotyped patterns in all complete IGHV-IGHD-IGHJ (V-D-J) sequences. Complete V-D-J rearrangements were identified in 130 of 165 patients. Most cases (89%) were highly mutated, but 12 sequences were truly unmutated or minimally mutated. Three genes, IGHV4-34, IGHV3-23, and IGHV4-39, accounted for one third of the whole cohort, including an overrepresentation of IGHV4-34 (15.5% overall). Interestingly, all IGHV4-34 rearrangements and all unmutated sequences belonged to the nongerminal center B-cell-like (non-GCB) subtype. Overall, we found three cases following the current criteria for stereotyped heavy chain VH CDR3 sequences, two of them belonging to subsets previously described in CLL. IGHV gene repertoire is remarkably biased, implying an antigen-driven origin in DLBCL. The particular features in the sequence of the immunoglobulins suggest the existence of particular subgroups within the non-GCB subtype.

摘要

弥漫性大 B 细胞淋巴瘤 (DLBCL) 的发病机制尚不完全清楚。对恶性细胞 B 细胞受体的分析有助于更好地了解 DLBCL 生物学。我们研究了 165 例未特指的 DLBCL 患者的免疫球蛋白重链 (IGH) 重排的分子特征。根据 BIOMED-2 方案扩增克隆性 IGH 重排,并直接对 PCR 产物进行测序。我们还分析了所有完整 IGHV-IGHD-IGHJ (V-D-J) 序列中规则模式的标准。在 165 例患者中,有 130 例确定了完整的 V-D-J 重排。大多数病例(89%)高度突变,但有 12 个序列是真正未突变或轻度突变。三个基因,IGHV4-34、IGHV3-23 和 IGHV4-39,占整个队列的三分之一,其中 IGHV4-34 过度表达(总体占 15.5%)。有趣的是,所有 IGHV4-34 重排和所有未突变序列均属于非生发中心 B 细胞样(非-GCB)亚型。总的来说,我们发现了 3 例符合当前规则重链 VH CDR3 序列标准的病例,其中 2 例属于 CLL 中先前描述的亚组。IGHV 基因库明显偏向,提示 DLBCL 存在抗原驱动的起源。免疫球蛋白序列的特殊特征表明非-GCB 亚型内存在特定的亚组。

相似文献

1
Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.弥漫性大 B 细胞淋巴瘤免疫球蛋白基因重排的分子特征:抗原驱动起源和 IGHV4-34 作为非生发中心 B 细胞亚型的一个特定亚群。
Am J Pathol. 2012 Nov;181(5):1879-88. doi: 10.1016/j.ajpath.2012.07.028. Epub 2012 Sep 11.
2
Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.塞尔维亚慢性淋巴细胞白血病患者中 IGHV-IGHD-IGHJ 重排的突变状态和基因库。
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):252-60. doi: 10.1016/j.clml.2012.03.005. Epub 2012 May 4.
3
IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.里氏转化的免疫球蛋白重链可变区(IgVH)突变状态及克隆性分析:弥漫性大B细胞淋巴瘤和霍奇金淋巴瘤合并B细胞慢性淋巴细胞白血病(B-CLL)代表了两种不同的疾病演变途径。
Am J Surg Pathol. 2007 Oct;31(10):1605-14. doi: 10.1097/PAS.0b013e31804bdaf8.
4
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.具有定型B细胞受体的慢性淋巴细胞白血病的分子和临床特征:一项意大利多中心研究的结果
Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19.
5
Molecular analysis of immunoglobulin genes in primary intraocular lymphoma.原发性眼内淋巴瘤免疫球蛋白基因的分子分析
Invest Ophthalmol Vis Sci. 2005 Oct;46(10):3507-14. doi: 10.1167/iovs.05-0401.
6
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.超过 30% 的边缘带脾淋巴瘤患者表达相同的免疫球蛋白重链可变基因:个体发生学意义。
Leukemia. 2012 Jul;26(7):1638-46. doi: 10.1038/leu.2012.3. Epub 2012 Jan 6.
7
Immunoglobulin heavy- and light-chain repertoire in splenic marginal zone lymphoma.脾边缘区淋巴瘤中的免疫球蛋白重链和轻链库
Mol Med. 2004 Jul-Dec;10(7-12):89-95. doi: 10.2119/2005-00001.Stamatopoulos.
8
Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.慢性淋巴细胞白血病中的免疫球蛋白轻链库
Blood. 2005 Nov 15;106(10):3575-83. doi: 10.1182/blood-2005-04-1511. Epub 2005 Aug 2.
9
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors.慢性淋巴细胞白血病中IGHV基因的插入和缺失:具有定型受体的部分病例中的“CLL偏向性”缺失
Eur J Immunol. 2006 Jul;36(7):1963-74. doi: 10.1002/eji.200535751.
10
Over-expression of BACH2 is related to ongoing somatic hypermutation of the immunoglobulin heavy chain gene variable region of de novo diffuse large B-cell lymphoma.BACH2 的过度表达与新诊断弥漫性大 B 细胞淋巴瘤免疫球蛋白重链基因可变区的持续体细胞超突变有关。
Pathol Int. 2013 Jul;63(7):339-44. doi: 10.1111/pin.12076.

引用本文的文献

1
Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review.奥妥珠单抗联合苯达莫司汀治疗变异型毛细胞白血病:一例报告及文献综述
Front Oncol. 2025 Aug 18;15:1635856. doi: 10.3389/fonc.2025.1635856. eCollection 2025.
2
Prognostic relevance of immunoglobulin heavy chain rearrangement and immunoglobulin kappa light chain rearrangement in patients with diffuse large B cell lymphoma.弥漫性大B细胞淋巴瘤患者中免疫球蛋白重链重排和免疫球蛋白κ轻链重排的预后相关性
Oncologist. 2025 Mar 10;30(3). doi: 10.1093/oncolo/oyaf016.
3
Biological Findings and Clinical Outcomes in Patients Treated With R-CHOP Plus High-Dose Methotrexate as First-Line Therapy in Large B-Cell Lymphoma With Testis Involvement.
以R-CHOP加用大剂量甲氨蝶呤作为一线治疗方案的睾丸受累大B细胞淋巴瘤患者的生物学发现与临床结局
Eur J Haematol. 2025 Jan;114(1):186-194. doi: 10.1111/ejh.14325. Epub 2024 Oct 12.
4
Complete detection of FR1 to FR3 primer-based PCR patterns of immunoglobulin heavy chain rearrangement in the BIOMED-2 protocol is associated with poor prognosis in patients with diffuse large B-cell lymphoma.在BIOMED-2方案中,完全检测到基于FR1至FR3引物的免疫球蛋白重链重排的PCR模式与弥漫性大B细胞淋巴瘤患者的不良预后相关。
EJHaem. 2024 Jun 18;5(4):698-708. doi: 10.1002/jha2.921. eCollection 2024 Aug.
5
Gastric DLBCL clonal evolution as function of patient age.胃弥漫性大 B 细胞淋巴瘤克隆进化与患者年龄的关系。
Front Immunol. 2022 Aug 29;13:957170. doi: 10.3389/fimmu.2022.957170. eCollection 2022.
6
Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside.用于B系恶性肿瘤微小残留病监测的下一代测序:从实验室到临床
Exp Hematol Oncol. 2022 Sep 3;11(1):50. doi: 10.1186/s40164-022-00300-2.
7
Follicular lymphoma subgroups with and without t(14;18) differ in their N-glycosylation pattern and IGHV usage.滤泡性淋巴瘤伴和不伴 t(14;18)的亚组在其 N-糖基化模式和 IGHV 使用上存在差异。
Blood Adv. 2021 Dec 14;5(23):4890-4900. doi: 10.1182/bloodadvances.2021005081.
8
Testicular Diffuse Large B-Cell Lymphoma-Clinical, Molecular, and Immunological Features.睾丸弥漫性大B细胞淋巴瘤——临床、分子及免疫学特征
Cancers (Basel). 2021 Aug 11;13(16):4049. doi: 10.3390/cancers13164049.
9
Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.原发性玻璃体视网膜淋巴瘤表现出显著受限的免疫球蛋白基因库。
Blood Adv. 2020 Apr 14;4(7):1357-1366. doi: 10.1182/bloodadvances.2019000980.
10
An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.EBNA3A 突变型 Epstein-Barr 病毒在脐血人源化小鼠模型中保留致淋巴瘤能力。
J Virol. 2020 May 4;94(10). doi: 10.1128/JVI.02168-19.